FMC - Wabash Valley is a medicare approved dialysis facility center in Terre Haute, Indiana and it has 2 dialysis stations. It is located in Vigo county at 4001 East Wabash Avenue, Terre Haute, IN, 47803. You can reach out to the office of FMC - Wabash Valley at (812) 234-1242. This dialysis clinic is managed and/or owned by Fresenius Medical Care. FMC - Wabash Valley has the following ownership type - Profit. It was first certified by medicare in January, 1995. The medicare id for this facility is 152532 and it accepts patients under medicare ESRD program.
| Name | FMC - Wabash Valley |
|---|---|
| Location | 4001 East Wabash Avenue, Terre Haute, Indiana |
| No. of Dialysis Stations | 2 |
| Medicare ID | 152532 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | No |
| 4001 East Wabash Avenue, Terre Haute, Indiana, 47803 | |
| (812) 234-1242 | |
| Not Available |
News Archive
The University of Illinois at Chicago has been selected as one of six research centers in the U.S. to help develop a comprehensive new strategy to control Ebola and other emerging infectious diseases in health facilities.
Ohr Pharmaceutical Inc. announced today it has selected Allen & Caron Inc, headquartered in Irvine, CA, with offices also in New York and London, as its agency for investor relations and corporate communications.
A selection of health policy stories from Michigan, Tennessee, California, Wisconsin, New York and North Carolina.
Two years ago, researchers at the University of South Australia discovered a new molecular marker specific for chemotherapy-induced cancer cell death. Now, those same investigators have used this marker to develop an imaging agent that can pinpoint tumor cell death using magnetic resonance imaging.
Oregon State University research has provided the first complete, cellular-level look at what's going on in joints afflicted by osteoarthritis, a debilitating and costly condition that affects nearly one-quarter of adults in the United States.
› Verified 8 days ago
| NPI Number | 1073618435 |
| Organization Name | Fresenius Medical Care Wabash Valley |
| Doing Business As | Bio-medical Applications Of Indiana, Inc. |
| Address | 4001 Wabash Ave Terre Haute, Indiana, 47803 |
| Phone Number | (812) 234-1242 |
News Archive
The University of Illinois at Chicago has been selected as one of six research centers in the U.S. to help develop a comprehensive new strategy to control Ebola and other emerging infectious diseases in health facilities.
Ohr Pharmaceutical Inc. announced today it has selected Allen & Caron Inc, headquartered in Irvine, CA, with offices also in New York and London, as its agency for investor relations and corporate communications.
A selection of health policy stories from Michigan, Tennessee, California, Wisconsin, New York and North Carolina.
Two years ago, researchers at the University of South Australia discovered a new molecular marker specific for chemotherapy-induced cancer cell death. Now, those same investigators have used this marker to develop an imaging agent that can pinpoint tumor cell death using magnetic resonance imaging.
Oregon State University research has provided the first complete, cellular-level look at what's going on in joints afflicted by osteoarthritis, a debilitating and costly condition that affects nearly one-quarter of adults in the United States.
› Verified 8 days ago
| Dialysis patients with Hemoglobin data | 18 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 22 |
News Archive
The University of Illinois at Chicago has been selected as one of six research centers in the U.S. to help develop a comprehensive new strategy to control Ebola and other emerging infectious diseases in health facilities.
Ohr Pharmaceutical Inc. announced today it has selected Allen & Caron Inc, headquartered in Irvine, CA, with offices also in New York and London, as its agency for investor relations and corporate communications.
A selection of health policy stories from Michigan, Tennessee, California, Wisconsin, New York and North Carolina.
Two years ago, researchers at the University of South Australia discovered a new molecular marker specific for chemotherapy-induced cancer cell death. Now, those same investigators have used this marker to develop an imaging agent that can pinpoint tumor cell death using magnetic resonance imaging.
Oregon State University research has provided the first complete, cellular-level look at what's going on in joints afflicted by osteoarthritis, a debilitating and costly condition that affects nearly one-quarter of adults in the United States.
› Verified 8 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular peritoneal dialysis at the center | 69 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 548 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | 98 |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
The University of Illinois at Chicago has been selected as one of six research centers in the U.S. to help develop a comprehensive new strategy to control Ebola and other emerging infectious diseases in health facilities.
Ohr Pharmaceutical Inc. announced today it has selected Allen & Caron Inc, headquartered in Irvine, CA, with offices also in New York and London, as its agency for investor relations and corporate communications.
A selection of health policy stories from Michigan, Tennessee, California, Wisconsin, New York and North Carolina.
Two years ago, researchers at the University of South Australia discovered a new molecular marker specific for chemotherapy-induced cancer cell death. Now, those same investigators have used this marker to develop an imaging agent that can pinpoint tumor cell death using magnetic resonance imaging.
Oregon State University research has provided the first complete, cellular-level look at what's going on in joints afflicted by osteoarthritis, a debilitating and costly condition that affects nearly one-quarter of adults in the United States.
› Verified 8 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at FMC - Wabash Valley with elevated calcium levels.
| Patients with hypercalcemia | 77 |
| Hypercalcemia patient months | 615 |
| Patients with Serumphosphor | 81 |
| Patients with Serumphosphor less than 3.5 mg/dL | 15 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 36 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 27 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 15 |
| Patients with Serumphosphor greater than 7 mg/dL | 6 |
News Archive
The University of Illinois at Chicago has been selected as one of six research centers in the U.S. to help develop a comprehensive new strategy to control Ebola and other emerging infectious diseases in health facilities.
Ohr Pharmaceutical Inc. announced today it has selected Allen & Caron Inc, headquartered in Irvine, CA, with offices also in New York and London, as its agency for investor relations and corporate communications.
A selection of health policy stories from Michigan, Tennessee, California, Wisconsin, New York and North Carolina.
Two years ago, researchers at the University of South Australia discovered a new molecular marker specific for chemotherapy-induced cancer cell death. Now, those same investigators have used this marker to develop an imaging agent that can pinpoint tumor cell death using magnetic resonance imaging.
Oregon State University research has provided the first complete, cellular-level look at what's going on in joints afflicted by osteoarthritis, a debilitating and costly condition that affects nearly one-quarter of adults in the United States.
› Verified 8 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 6 |
| Patient months included in arterial venous fistula and catheter summaries | 28 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer |
News Archive
The University of Illinois at Chicago has been selected as one of six research centers in the U.S. to help develop a comprehensive new strategy to control Ebola and other emerging infectious diseases in health facilities.
Ohr Pharmaceutical Inc. announced today it has selected Allen & Caron Inc, headquartered in Irvine, CA, with offices also in New York and London, as its agency for investor relations and corporate communications.
A selection of health policy stories from Michigan, Tennessee, California, Wisconsin, New York and North Carolina.
Two years ago, researchers at the University of South Australia discovered a new molecular marker specific for chemotherapy-induced cancer cell death. Now, those same investigators have used this marker to develop an imaging agent that can pinpoint tumor cell death using magnetic resonance imaging.
Oregon State University research has provided the first complete, cellular-level look at what's going on in joints afflicted by osteoarthritis, a debilitating and costly condition that affects nearly one-quarter of adults in the United States.
› Verified 8 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 67 |
| Hospitalization Rate in facility | 230.3 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 381.8 |
| Hospitalization Rate: Lower Confidence Limit | 142.8 |
News Archive
The University of Illinois at Chicago has been selected as one of six research centers in the U.S. to help develop a comprehensive new strategy to control Ebola and other emerging infectious diseases in health facilities.
Ohr Pharmaceutical Inc. announced today it has selected Allen & Caron Inc, headquartered in Irvine, CA, with offices also in New York and London, as its agency for investor relations and corporate communications.
A selection of health policy stories from Michigan, Tennessee, California, Wisconsin, New York and North Carolina.
Two years ago, researchers at the University of South Australia discovered a new molecular marker specific for chemotherapy-induced cancer cell death. Now, those same investigators have used this marker to develop an imaging agent that can pinpoint tumor cell death using magnetic resonance imaging.
Oregon State University research has provided the first complete, cellular-level look at what's going on in joints afflicted by osteoarthritis, a debilitating and costly condition that affects nearly one-quarter of adults in the United States.
› Verified 8 days ago
The rate of readmission show you whether patients who were being treated regularly at FMC - Wabash Valley were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 36.2 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 49.3 |
| Readmission Rate: Lower Confidence Limit | 24.9 |
News Archive
The University of Illinois at Chicago has been selected as one of six research centers in the U.S. to help develop a comprehensive new strategy to control Ebola and other emerging infectious diseases in health facilities.
Ohr Pharmaceutical Inc. announced today it has selected Allen & Caron Inc, headquartered in Irvine, CA, with offices also in New York and London, as its agency for investor relations and corporate communications.
A selection of health policy stories from Michigan, Tennessee, California, Wisconsin, New York and North Carolina.
Two years ago, researchers at the University of South Australia discovered a new molecular marker specific for chemotherapy-induced cancer cell death. Now, those same investigators have used this marker to develop an imaging agent that can pinpoint tumor cell death using magnetic resonance imaging.
Oregon State University research has provided the first complete, cellular-level look at what's going on in joints afflicted by osteoarthritis, a debilitating and costly condition that affects nearly one-quarter of adults in the United States.
› Verified 8 days ago